NanoBio Corporation Awarded Licensing Executive Society's "Deal of Distinction" for Licensing Agreement with GlaxoSmithKline
ANN ARBOR, Mich.--(BUSINESS WIRE)--NanoBio Corporation today announced that the Company’s licensing agreement with GlaxoSmithKline has been recognized by the Licensing Executive Society, Inc. (LES) as the 2009 consumer products “Deal of Distinction.” LES recognizes noteworthy deals in five industry sectors that promote innovation solutions to business issues and deal structures.